Boxed Warning on risk of severe hypocalcaemia with denosumab

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 1992卷 / 1期

关键词：

D O I：

10.1007/s40278-024-52736-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[21] Infection risk upgraded from bolded to boxed warning for Enbrel
Reactions Weekly, 2008, 1194-1195 (1) : 3 - 3
[22] Denosumab/prednisoneOsteoporosis and hypocalcaemia: case report
Reactions Weekly, 2024, 2029 (1) : 211 - 211
[23] PRESCRIBER BEWARE: SEVERE HYPOCALCAEMIA AFTER DENOSUMAB AND IRON INFUSION IN CHRONIC KIDNEY DISEASE
Cohen, A. W. S.
Chacko, B.
NEPHROLOGY, 2021, 26 : 51 - 51
[24] Identification of risk factors and development of detection algorithm for denosumab-induced hypocalcaemia
Imatoh, Takuya
Sai, Kimie
Takeyama, Mayu
Hori, Katsuhito
Karayama, Masato
Furuhashi, Kazuki
Segawa, Katsunori
Kimura, Michio
Kawakami, Junichi
Saito, Yoshiro
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (01) : 62 - 68
[25] PHARMACOEPIDEMIOLOGY AND THE IMPACT OF THE BOXED WARNING
Bridge, Jeff
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S114 - S114
[26] New boxed warning for Tygacil
Reactions Weekly, 2013, 1472 (1) : 3 - 3
[27] Boxed warning for lamotrigine in US
Reactions Weekly, 1997, 647 (1) : 2 - 2
[28] New boxed warning for leflunomide
Reactions Weekly, 2010, 1311 (1) : 6 - 6
[29] Boxed warning added to `Cafergot'
Reactions Weekly, 2002, 929 (1) : 2 - 2
[30] Denosumab/ironHypophosphataemia and hypocalcaemia: 2 case reports
Reactions Weekly, 2023, 1976 (1) : 129 - 129

← 1 2 3 4 5 →